ID   ASNS_HUMAN              Reviewed;         561 AA.
AC   P08243; A4D1I8; B4DXZ1; B7ZAA9; D6W5R3; E9PCI3; E9PCX6; P08184;
AC   Q15666; Q549T9; Q96HD0;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 192.
DE   RecName: Full=Asparagine synthetase [glutamine-hydrolyzing];
DE            EC=6.3.5.4;
DE   AltName: Full=Cell cycle control protein TS11;
DE   AltName: Full=Glutamine-dependent asparagine synthetase;
GN   Name=ASNS; Synonyms=TS11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2886907; DOI=10.1128/MCB.7.7.2435;
RA   Andrulis I.L., Chen J., Ray P.N.;
RT   "Isolation of human cDNAs for asparagine synthetase and expression in
RT   Jensen rat sarcoma cells.";
RL   Mol. Cell. Biol. 7:2435-2443(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2565875; DOI=10.1016/0888-7543(89)90329-7;
RA   Zhang Y.P., Lambert M.A., Cairney A.E., Wills D., Ray P.N.,
RA   Andrulis I.L.;
RT   "Molecular structure of the human asparagine synthetase gene.";
RL   Genomics 4:259-265(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   GLU-210.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-210.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-210.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-210.
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLU-210.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 23-561 (ISOFORM 1).
RX   PubMed=3470743; DOI=10.1073/pnas.84.6.1565;
RA   Greco A., Ittmann M., Basilico C.;
RT   "Molecular cloning of a gene that is necessary for G1 progression in
RT   mammalian cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:1565-1569(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-83.
RX   PubMed=2569668; DOI=10.1128/MCB.9.6.2350;
RA   Greco A., Gong S.S., Ittmann M., Basilico C.;
RT   "Organization and expression of the cell cycle gene, ts11, that
RT   encodes asparagine synthetase.";
RL   Mol. Cell. Biol. 9:2350-2359(1989).
RN   [11]
RP   ACTIVE SITE.
RX   PubMed=2564390;
RA   van Heeke G., Schuster S.M.;
RT   "Expression of human asparagine synthetase in Escherichia coli.";
RL   J. Biol. Chem. 264:5503-5509(1989).
RN   [12]
RP   MUTAGENESIS OF CYS-2, CATALYTIC ACTIVITY, AND ACTIVE SITE.
RX   PubMed=2573597;
RA   van Heeke G., Schuster S.M.;
RT   "The N-terminal cysteine of human asparagine synthetase is essential
RT   for glutamine-dependent activity.";
RL   J. Biol. Chem. 264:19475-19477(1989).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-385, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-545 AND SER-557, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANTS ASNSD GLU-6; VAL-362 AND CYS-550, AND CHARACTERIZATION OF
RP   VARIANTS ASNSD GLU-6; VAL-362 AND CYS-550.
RX   PubMed=24139043; DOI=10.1016/j.neuron.2013.08.013;
RA   Ruzzo E.K., Capo-Chichi J.M., Ben-Zeev B., Chitayat D., Mao H.,
RA   Pappas A.L., Hitomi Y., Lu Y.F., Yao X., Hamdan F.F., Pelak K.,
RA   Reznik-Wolf H., Bar-Joseph I., Oz-Levi D., Lev D., Lerman-Sagie T.,
RA   Leshinsky-Silver E., Anikster Y., Ben-Asher E., Olender T.,
RA   Colleaux L., Decarie J.C., Blaser S., Banwell B., Joshi R.B., He X.P.,
RA   Patry L., Silver R.J., Dobrzeniecka S., Islam M.S., Hasnat A.,
RA   Samuels M.E., Aryal D.K., Rodriguiz R.M., Jiang Y.H., Wetsel W.C.,
RA   McNamara J.O., Rouleau G.A., Silver D.L., Lancet D., Pras E.,
RA   Mitchell G.A., Michaud J.L., Goldstein D.B.;
RT   "Deficiency of asparagine synthetase causes congenital microcephaly
RT   and a progressive form of encephalopathy.";
RL   Neuron 80:429-441(2013).
CC   -!- CATALYTIC ACTIVITY: ATP + L-aspartate + L-glutamine + H(2)O = AMP
CC       + diphosphate + L-asparagine + L-glutamate.
CC       {ECO:0000269|PubMed:2573597}.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-asparagine biosynthesis; L-
CC       asparagine from L-aspartate (L-Gln route): step 1/1.
CC   -!- INTERACTION:
CC       Q86WT6:TRIM69; NbExp=3; IntAct=EBI-722989, EBI-749955;
CC       A2RRH5:WDR27; NbExp=3; IntAct=EBI-722989, EBI-9476803;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P08243-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P08243-2; Sequence=VSP_045818;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P08243-3; Sequence=VSP_045817;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Asparagine synthetase deficiency (ASNSD) [MIM:615574]: An
CC       inborn error of asparagine biosynthesis that results in a severe
CC       neurologic disorder characterized by microcephaly, severely
CC       delayed psychomotor development, progressive encephalopathy,
CC       cortical atrophy, and seizure or hyperekplexic activity.
CC       {ECO:0000269|PubMed:24139043}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ASNSID44323ch7q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M27396; AAA51789.1; -; mRNA.
DR   EMBL; L35946; AAA52756.1; -; Genomic_DNA.
DR   EMBL; L35936; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35937; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35938; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35939; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35940; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35941; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35942; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35943; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35944; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; L35945; AAA52756.1; JOINED; Genomic_DNA.
DR   EMBL; BT007113; AAP35777.1; -; mRNA.
DR   EMBL; AK302189; BAG63553.1; -; mRNA.
DR   EMBL; AK316224; BAH14595.1; -; mRNA.
DR   EMBL; AC005326; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079781; AAQ96856.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24115.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76730.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76723.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76731.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76732.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76733.1; -; Genomic_DNA.
DR   EMBL; BC008723; AAH08723.1; -; mRNA.
DR   EMBL; BC014621; AAH14621.1; -; mRNA.
DR   EMBL; M15798; AAA36781.1; -; mRNA.
DR   EMBL; M27054; AAA63266.1; -; Genomic_DNA.
DR   CCDS; CCDS55131.1; -. [P08243-3]
DR   CCDS; CCDS55132.1; -. [P08243-2]
DR   CCDS; CCDS5652.1; -. [P08243-1]
DR   PIR; A27062; AJHUN1.
DR   RefSeq; NP_001171546.1; NM_001178075.1. [P08243-2]
DR   RefSeq; NP_001171547.1; NM_001178076.1. [P08243-3]
DR   RefSeq; NP_001171548.1; NM_001178077.1. [P08243-3]
DR   RefSeq; NP_001664.3; NM_001673.4. [P08243-1]
DR   RefSeq; NP_597680.2; NM_133436.3. [P08243-1]
DR   RefSeq; NP_899199.2; NM_183356.3. [P08243-1]
DR   UniGene; Hs.489207; -.
DR   ProteinModelPortal; P08243; -.
DR   SMR; P08243; -.
DR   BioGrid; 106932; 82.
DR   IntAct; P08243; 9.
DR   MINT; MINT-1371662; -.
DR   STRING; 9606.ENSP00000175506; -.
DR   BindingDB; P08243; -.
DR   ChEMBL; CHEMBL3120; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB00174; L-Asparagine.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00130; L-Glutamine.
DR   MEROPS; C44.974; -.
DR   iPTMnet; P08243; -.
DR   PhosphoSitePlus; P08243; -.
DR   SwissPalm; P08243; -.
DR   BioMuta; ASNS; -.
DR   DMDM; 13432102; -.
DR   EPD; P08243; -.
DR   MaxQB; P08243; -.
DR   PaxDb; P08243; -.
DR   PeptideAtlas; P08243; -.
DR   PRIDE; P08243; -.
DR   DNASU; 440; -.
DR   Ensembl; ENST00000175506; ENSP00000175506; ENSG00000070669. [P08243-1]
DR   Ensembl; ENST00000394308; ENSP00000377845; ENSG00000070669. [P08243-1]
DR   Ensembl; ENST00000394309; ENSP00000377846; ENSG00000070669. [P08243-1]
DR   Ensembl; ENST00000422745; ENSP00000414901; ENSG00000070669. [P08243-2]
DR   Ensembl; ENST00000437628; ENSP00000414379; ENSG00000070669. [P08243-3]
DR   Ensembl; ENST00000444334; ENSP00000406994; ENSG00000070669. [P08243-2]
DR   Ensembl; ENST00000455086; ENSP00000408472; ENSG00000070669. [P08243-3]
DR   GeneID; 440; -.
DR   KEGG; hsa:440; -.
DR   UCSC; uc003uot.5; human. [P08243-1]
DR   CTD; 440; -.
DR   DisGeNET; 440; -.
DR   GeneCards; ASNS; -.
DR   HGNC; HGNC:753; ASNS.
DR   HPA; HPA004924; -.
DR   HPA; HPA029318; -.
DR   HPA; HPA064737; -.
DR   MalaCards; ASNS; -.
DR   MIM; 108370; gene.
DR   MIM; 615574; phenotype.
DR   neXtProt; NX_P08243; -.
DR   OpenTargets; ENSG00000070669; -.
DR   Orphanet; 391376; Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome.
DR   PharmGKB; PA25052; -.
DR   eggNOG; KOG0571; Eukaryota.
DR   eggNOG; COG0367; LUCA.
DR   GeneTree; ENSGT00390000001994; -.
DR   HOGENOM; HOG000027493; -.
DR   HOVERGEN; HBG003103; -.
DR   InParanoid; P08243; -.
DR   KO; K01953; -.
DR   OMA; DWSGIYS; -.
DR   OrthoDB; EOG091G13BD; -.
DR   PhylomeDB; P08243; -.
DR   TreeFam; TF300603; -.
DR   BRENDA; 6.3.5.4; 2681.
DR   Reactome; R-HSA-380994; ATF4 activates genes.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   UniPathway; UPA00134; UER00195.
DR   GenomeRNAi; 440; -.
DR   PRO; PR:P08243; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000070669; -.
DR   CleanEx; HS_ASNS; -.
DR   ExpressionAtlas; P08243; baseline and differential.
DR   Genevisible; P08243; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0004066; F:asparagine synthase (glutamine-hydrolyzing) activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0048037; F:cofactor binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IBA:GO_Central.
DR   GO; GO:0006529; P:asparagine biosynthetic process; IDA:MGI.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0070981; P:L-asparagine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0032354; P:response to follicle-stimulating hormone; IEA:Ensembl.
DR   GO; GO:0009416; P:response to light stimulus; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0031427; P:response to methotrexate; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   CDD; cd01991; Asn_Synthase_B_C; 1.
DR   CDD; cd00712; AsnB; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR006426; Asn_synth_AEB.
DR   InterPro; IPR001962; Asn_synthase.
DR   InterPro; IPR033738; AsnB_N.
DR   InterPro; IPR017932; GATase_2_dom.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00733; Asn_synthase; 1.
DR   Pfam; PF13537; GATase_7; 1.
DR   SUPFAM; SSF56235; SSF56235; 1.
DR   TIGRFAMs; TIGR01536; asn_synth_AEB; 1.
DR   PROSITE; PS51278; GATASE_TYPE_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Amino-acid biosynthesis;
KW   Asparagine biosynthesis; ATP-binding; Complete proteome;
KW   Disease mutation; Glutamine amidotransferase; Ligase;
KW   Mental retardation; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250}.
FT   CHAIN         2    561       Asparagine synthetase [glutamine-
FT                                hydrolyzing].
FT                                /FTId=PRO_0000056910.
FT   DOMAIN        2    191       Glutamine amidotransferase type-2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00609}.
FT   DOMAIN      213    536       Asparagine synthetase.
FT   NP_BIND     363    364       ATP. {ECO:0000250}.
FT   REGION       49     53       Glutamine binding. {ECO:0000250}.
FT   REGION       75     77       Glutamine binding. {ECO:0000250}.
FT   ACT_SITE      2      2       For GATase activity.
FT                                {ECO:0000269|PubMed:2564390,
FT                                ECO:0000269|PubMed:2573597}.
FT   BINDING      97     97       Glutamine. {ECO:0000250}.
FT   BINDING     256    256       ATP; via carbonyl oxygen. {ECO:0000250}.
FT   BINDING     288    288       ATP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   SITE        365    365       Important for beta-aspartyl-AMP
FT                                intermediate formation. {ECO:0000250}.
FT   MOD_RES     385    385       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     545    545       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     557    557       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     83       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045817.
FT   VAR_SEQ       1     21       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045818.
FT   VARIANT       6      6       A -> E (in ASNSD; dramatic reduction in
FT                                protein abundance; dbSNP:rs398122975).
FT                                {ECO:0000269|PubMed:24139043}.
FT                                /FTId=VAR_070896.
FT   VARIANT     210    210       V -> E (in dbSNP:rs1049674).
FT                                {ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:12853948,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_023443.
FT   VARIANT     362    362       F -> V (in ASNSD; dramatic reduction in
FT                                protein abundance; dbSNP:rs398122973).
FT                                {ECO:0000269|PubMed:24139043}.
FT                                /FTId=VAR_070897.
FT   VARIANT     550    550       R -> C (in ASNSD; increases level of
FT                                protein abundance; dbSNP:rs398122974).
FT                                {ECO:0000269|PubMed:24139043}.
FT                                /FTId=VAR_070898.
FT   MUTAGEN       2      2       C->A: Loss of the glutamine-dependent
FT                                asparagine synthetase activity, while the
FT                                ammonia-dependent activity remained
FT                                unaffected. {ECO:0000269|PubMed:2573597}.
FT   CONFLICT    333    343       TYDITTVRASV -> LMTLQQFVLRI (in Ref. 9;
FT                                AAA36781). {ECO:0000305}.
FT   CONFLICT    353    360       RKNTDSVV -> GRTQIAWL (in Ref. 9;
FT                                AAA36781). {ECO:0000305}.
FT   CONFLICT    426    426       S -> F (in Ref. 1 and 2). {ECO:0000305}.
FT   CONFLICT    462    462       I -> V (in Ref. 4; BAG63553).
FT                                {ECO:0000305}.
SQ   SEQUENCE   561 AA;  64370 MW;  3E9B75E21D799FBE CRC64;
     MCGIWALFGS DDCLSVQCLS AMKIAHRGPD AFRFENVNGY TNCCFGFHRL AVVDPLFGMQ
     PIRVKKYPYL WLCYNGEIYN HKKMQQHFEF EYQTKVDGEI ILHLYDKGGI EQTICMLDGV
     FAFVLLDTAN KKVFLGRDTY GVRPLFKAMT EDGFLAVCSE AKGLVTLKHS ATPFLKVEPF
     LPGHYEVLDL KPNGKVASVE MVKYHHCRDV PLHALYDNVE KLFPGFEIET VKNNLRILFN
     NAVKKRLMTD RRIGCLLSGG LDSSLVAATL LKQLKEAQVQ YPLQTFAIGM EDSPDLLAAR
     KVADHIGSEH YEVLFNSEEG IQALDEVIFS LETYDITTVR ASVGMYLISK YIRKNTDSVV
     IFSGEGSDEL TQGYIYFHKA PSPEKAEEES ERLLRELYLF DVLRADRTTA AHGLELRVPF
     LDHRFSSYYL SLPPEMRIPK NGIEKHLLRE TFEDSNLIPK EILWRPKEAF SDGITSVKNS
     WFKILQEYVE HQVDDAMMAN AAQKFPFNTP KTKEGYYYRQ VFERHYPGRA DWLSHYWMPK
     WINATDPSAR TLTHYKSAVK A
//
